Industry seeks phased-in approach to drug supply chain tracking requirements
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesDSCSAPharmaceuticalsSupply Chain ManagementUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesDSCSAPharmaceuticalsSupply Chain ManagementUnited StatesUS Food and Drug Administration (FDA)